Document Detail


The Regulation of Veterinary Regenerative Medicine and the Potential Impact of Such Regulation on Clinicians and Firms Commercializing These Treatments.
MedLine Citation:
PMID:  21872766     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
This article provides an overview of the US Food and Drug Administration's current and potential regulation of veterinary regenerative medicine and the various products used in the practice. This article also discusses several of the potential enforcement risks associated with the commercialization of such therapies and products and offers the reader strategies for mitigating those risks. Finally, the article concludes with a review of an important and ongoing court battle that focuses on the marketing and promotion of cellular-based therapies for humans that could have a significant impact on the regulation of both human and veterinary products.
Authors:
Karl M Nobert
Related Documents :
21783906 - Prioritizing veterinary pharmaceuticals for aquatic environment in korea.
22557226 - Preliminary phytochemical studies on solanum surattense burm.f. seeds.
17162696 - Administrative issues involved in disaster management in india.
21776926 - Nhs reform: 'realising each place's potential'.
17139016 - Technology as an instrument to improve quality, accountability, and reflection in acade...
6755326 - Premature rupture of the membranes.
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  The Veterinary clinics of North America. Equine practice     Volume:  27     ISSN:  1558-4224     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8511904     Medline TA:  Vet Clin North Am Equine Pract     Country:  -    
Other Details:
Languages:  ENG     Pagination:  383-391     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier Inc.
Affiliation:
K&L Gates LLP, 1601 K Street, NW, Washington, DC 20006, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evidence-Based Medicine and Stem Cell Therapy: How Do We Know Such Technologies are Safe and Effic...
Next Document:  Cell-based Therapies: Current Issues and Future Directions.